Amanote Research
Register
Sign In
221. TRAIL-R2 and HRK Mediate Angiotensin Type 2 Receptor-Induced Apoptosis of Human Prostate Cancer Cells
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)34556-7
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2013
Authors
Unknown
Publisher
Elsevier BV
Related search
TRAIL (APO-2L) Induces Apoptosis in Human Prostate Cancer Cells That Is Inhibitable by BCL-2
Oncogene
Cancer Research
Genetics
Molecular Biology
MUC16 Mucin (CA125) Attenuates TRAIL-induced Apoptosis by Decreasing TRAIL Receptor R2 Expression and Increasing C-Flip Expression
BMC Cancer
Cancer Research
Oncology
Genetics
S-Phase Checkpoints Regulate Apo2 Ligand/Trail and CPT-11-induced Apoptosis of Prostate Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Luteolin Sensitizes Human Liver Cancer Cells to TRAIL‑induced Apoptosis via Autophagy and JNK‑mediated Death Receptor 5 Upregulation
International Journal of Oncology
Cancer Research
Oncology
Butyrate-Induced Apoptosis in Prostate Cancer Cells
SKP2 Confers Resistance of Pancreatic Cancer Cells Towards TRAIL-induced Apoptosis
International Journal of Oncology
Cancer Research
Oncology
High Susceptibility of Metastatic Cells Derived From Human Prostate and Colon Cancer Cells to TRAIL and Sensitization of TRAIL-insensitive Primary Cells to TRAIL by 4,5-Dimethoxy-2-Nitrobenzaldehyde
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
TRAIL-induced Apoptosis of Thyroid Cancer Cells: Potential for Therapeutic Intervention
Oncogene
Cancer Research
Genetics
Molecular Biology
Cannabinoid Receptor Agonist-Induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds Through Sustained Activation of ERK1/2 Leading to G1Cell Cycle Arrest
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
